Dashboard
1
Weak Long Term Fundamental Strength with a -32.53% CAGR growth in Operating Profits over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 8.21% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 5 consecutive quarters
3
Risky -
4
Below par performance in long term as well as near term
Stock DNA
Chemicals & Petrochemicals
EUR 1,472 Million ()
NA (Loss Making)
NA
0.06%
0.46
-6.20%
0.38
Revenue and Profits:
Net Sales:
1,466 Million
(Quarterly Results - Jun 2025)
Net Profit:
-45 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-67.09%
0%
-67.09%
6 Months
-61.15%
0%
-61.15%
1 Year
-73.64%
0%
-73.64%
2 Years
-74.24%
0%
-74.24%
3 Years
-78.69%
0%
-78.69%
4 Years
-72.09%
0%
-72.09%
5 Years
-69.19%
0%
-69.19%
LANXESS AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.34%
EBIT Growth (5y)
-44.01%
EBIT to Interest (avg)
4.14
Debt to EBITDA (avg)
2.59
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.88
Tax Ratio
32.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
5.01%
ROE (avg)
8.21%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.46
EV to EBIT
59.29
EV to EBITDA
5.57
EV to Capital Employed
0.64
EV to Sales
0.64
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
1.09%
ROE (Latest)
-4.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
1,466.00
1,601.00
-8.43%
Operating Profit (PBDIT) excl Other Income
239.00
138.00
73.19%
Interest
10.00
12.00
-16.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-45.00
-57.00
21.05%
Operating Profit Margin (Excl OI)
15.00%
1.90%
1.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -8.43% vs 7.96% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 21.05% vs 10.94% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
6,366.00
6,714.00
-5.18%
Operating Profit (PBDIT) excl Other Income
609.00
522.00
16.67%
Interest
47.00
70.00
-32.86%
Exceptional Items
-84.00
-646.00
87.00%
Consolidate Net Profit
-176.00
-842.00
79.10%
Operating Profit Margin (Excl OI)
7.70%
-6.00%
1.37%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -5.18% vs -16.99% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 79.10% vs -555.14% in Dec 2023
About LANXESS AG 
LANXESS AG
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






